BRPI0615555A2 - composições e métodos para o controle de angiogênese com cupredoxinas - Google Patents

composições e métodos para o controle de angiogênese com cupredoxinas

Info

Publication number
BRPI0615555A2
BRPI0615555A2 BRPI0615555-3A BRPI0615555A BRPI0615555A2 BR PI0615555 A2 BRPI0615555 A2 BR PI0615555A2 BR PI0615555 A BRPI0615555 A BR PI0615555A BR PI0615555 A2 BRPI0615555 A2 BR PI0615555A2
Authority
BR
Brazil
Prior art keywords
angiogenesis
compositions
cupredoxin
methods
specifically
Prior art date
Application number
BRPI0615555-3A
Other languages
English (en)
Inventor
Rajeshwari Mehta
Brad Taylor
Tohru Yamada
Craig Beattle
Tapas Das Gupta
Ananda Chakrabarty
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Priority claimed from US11/436,592 external-priority patent/US7381701B2/en
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of BRPI0615555A2 publication Critical patent/BRPI0615555A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Abstract

COMPOSIçõES E MéTODOS PARá O CONTROLE DE ANGIOGêNESE COM CUPREDOXINAS. Compreendendo cupredoxinas e seu uso para inibir a angiogênese em células de mamíferos, tecidos e animais e, especificamente, a angiogênese que acompanha o desenvolvimento de tumor e particularmente em humanos. Especificamente, a presente invenção se refere a composições que compreendem cupredoxina(s) e/ou peptídeos que são variantes, derivadas ou equivalentes estruturais das cupredoxinas, que tém a capacidade de inibir a angiogénese em células de mamíferos, tecidos ou animais. Estas composições podem ser, entre outras, peptídeos ou composições farmacêuticas. As composições da invenção podem ser utilizadas no tratamento de qualquer condição patológica que tem sintoma ou causa, a angiogênese inadequada e, especificamente, a angiogênese inadequada relacionada com o desenvolvimento de tumor.
BRPI0615555-3A 2005-07-19 2006-07-19 composições e métodos para o controle de angiogênese com cupredoxinas BRPI0615555A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US70029705P 2005-07-19 2005-07-19
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US76474906P 2006-02-03 2006-02-03
US11/436,592 US7381701B2 (en) 2001-02-15 2006-05-19 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
PCT/US2006/027940 WO2007024368A2 (en) 2005-07-19 2006-07-19 Compositions and methods to control angiogenesis with cupredoxins

Publications (1)

Publication Number Publication Date
BRPI0615555A2 true BRPI0615555A2 (pt) 2009-07-14

Family

ID=37772089

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0615555-3A BRPI0615555A2 (pt) 2005-07-19 2006-07-19 composições e métodos para o controle de angiogênese com cupredoxinas

Country Status (10)

Country Link
EP (1) EP1904081A4 (pt)
JP (1) JP2009502797A (pt)
KR (1) KR20080034905A (pt)
AU (1) AU2006284490A1 (pt)
BR (1) BRPI0615555A2 (pt)
CA (1) CA2615560A1 (pt)
IL (1) IL188691A0 (pt)
MX (1) MX2008000993A (pt)
NO (1) NO20080829L (pt)
WO (1) WO2007024368A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158574B2 (en) * 2004-10-07 2012-04-17 Cdg Therapeutics, Inc. Compositions and methods to prevent cancer with cupredoxins
JP2010503409A (ja) * 2006-09-14 2010-02-04 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ クプレドキシンによって癌を予防する組成物および方法
BRPI0718360A2 (pt) * 2006-12-04 2013-11-12 Univ Illinois "composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg"

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691383B2 (en) * 2004-10-07 2010-04-06 The Board Of Trustees Of The University Of Illinois Cupredoxin derived transport agents and methods of use thereof
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
AU2006251644A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating HIV infection with cupredoxin and cytochrome c
KR20080019615A (ko) * 2005-05-20 2008-03-04 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 쿠프레독신과 시토크롬으로 말라리아를 치료하기 위한조성물과 방법
EP1888106A4 (en) * 2005-05-20 2009-01-14 Univ Illinois COMPOSITIONS AND METHODS FOR TREATING EPHRIN SIGNALING WITH CUPREDOXINES

Also Published As

Publication number Publication date
MX2008000993A (es) 2008-03-19
EP1904081A4 (en) 2008-12-03
WO2007024368A3 (en) 2007-10-11
AU2006284490A1 (en) 2007-03-01
WO2007024368A2 (en) 2007-03-01
KR20080034905A (ko) 2008-04-22
JP2009502797A (ja) 2009-01-29
NO20080829L (no) 2008-04-02
EP1904081A2 (en) 2008-04-02
CA2615560A1 (en) 2007-03-01
AU2006284490A8 (en) 2008-02-28
IL188691A0 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
Lagunas-Rangel et al. Learning of nature: The curious case of the naked mole rat
UY28396A1 (es) Trompas de vegf y usos terapéuticos de las mismas
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
WO2007035213A3 (en) Transgenic ungulates expressing ctla4-ig and uses thereof
BRPI0410185A (pt) composição para manter a viabilidade de um orgão e célula
BRPI0615265A8 (pt) composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
BRPI0814097A8 (pt) Derivado do peptídeo insulinotrópico cm seu aminoácido n-terminal modificado
TR201809592T4 (tr) Aktif içerik maddelerinin bileşimleri.
BRPI0819714A8 (pt) Formulações de proteína e métodos de produção das mesmas
NO20064584L (no) Tetrahydropyridoindolderivater
HK1134283A1 (en) Arylsulfonamide compounds
WO2006076646A3 (en) Heteroaryl substituted quinolin-4-ylamine analogues
WO2006081388A3 (en) Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
MX2009002787A (es) Composiciones y métodos para prevenir el cáncer con cupredoxinas.
WO2009047568A3 (en) In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
Kang et al. Beneficial effects of dried pomegranate juice concentrated powder on ultraviolet B-induced skin photoaging in hairless mice
CL2007001748A1 (es) Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras.
BRPI0615555A2 (pt) composições e métodos para o controle de angiogênese com cupredoxinas
BRPI0606528A2 (pt) composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma
Cui et al. Glutamine protects myocardial ischemia-reperfusion injury in rats through the PI3K/Akt signaling pathway.
TR201901268T4 (tr) Mezenkimal kök hücreleri ve bunların kullanımları.
BR112016006512A2 (pt) kits de conservação de órgãos, órgão, solução e métodos para preparar solução para conservação de órgãos ou tecidos e tecidos vivos
EA200600468A1 (ru) Биполярные транс-каротиноидные соли и их применение
ES2491565T3 (es) Agente de transfección
AR048583A1 (es) Derivados radiohalogenados de benzamida y su uso en el diagnostico y la terapia de tumores

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOI

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018080036611/SP DE 13/06/2008.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2143 DE 31/01/2012.